99 related articles for article (PubMed ID: 7199554)
1. [Chemotherapy for advanced gynecological carcinoma with cis-dichlorodiammineplatinum (II), adriamycin and/or cyclophosphamide after failure of initial treatment (author's transl)].
Takizawa K; Matsuzawa M; Takahashi M; So E; Hasumi K; Sampi K
Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1292-1302. PubMed ID: 7199554
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
[TBL] [Abstract][Full Text] [Related]
3. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
Sanz Ortiz J; Saiz García F
Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
[No Abstract] [Full Text] [Related]
4. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
Eagan RT; Frytak S; Creagan ET; Ingle JN; Kvols LK; Coles DT
Cancer Treat Rep; 1979; 63(9-10):1589-91. PubMed ID: 227597
[No Abstract] [Full Text] [Related]
5. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
[TBL] [Abstract][Full Text] [Related]
6. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
[TBL] [Abstract][Full Text] [Related]
7. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
[No Abstract] [Full Text] [Related]
8. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for advanced carcinoma of the fallopian tube.
Deppe G; Bruckner HW; Cohen CJ
Obstet Gynecol; 1980 Oct; 56(4):530-2. PubMed ID: 7191548
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).
Issell BF; Valdivieso M; Bodey GP
Cancer Treat Rep; 1978 Jul; 62(7):1089-91. PubMed ID: 210943
[No Abstract] [Full Text] [Related]
11. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
Ehrlich CE; Einhorn L; Williams SD; Morgan J
Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
[No Abstract] [Full Text] [Related]
12. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
[TBL] [Abstract][Full Text] [Related]
14. The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).
Vogl SE; Berenzweig M; Kaplan BH; Moukhtar M; Bulkin W
Cancer Treat Rep; 1979 Feb; 63(2):311-7. PubMed ID: 109202
[TBL] [Abstract][Full Text] [Related]
15. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Athanassiades P; Bacoyiannes H; Kontoyiannes D
Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
[TBL] [Abstract][Full Text] [Related]
16. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide, Adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinoma.
Lele SB; Piver MS; Barlow JJ
Gynecol Oncol; 1983 Aug; 16(1):15-8. PubMed ID: 6688405
[TBL] [Abstract][Full Text] [Related]
18. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine, and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
Nakanishi F; Mogi H; Sugiishi M; Sugiura I; Ogasawara T; Kinoshita T; Hoshino A
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3413-8. PubMed ID: 3466573
[TBL] [Abstract][Full Text] [Related]
20. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
Takita H; Marabella PC; Edgerton F; Rizzo D
Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
